Document Type
Article
Date of Original Version
4-24-2018
Department
Biomedical and Pharmaceutical Sciences
Abstract
Human epididymis protein 4 (HE4) is an important clinical biomarker used for the detection of epithelial ovarian cancer (EOC). While much is known about the predictive power of HE4 clinically, less has been reported regarding its molecular role in the progression of EOC. A deeper understanding of HE4’s mechanistic functions may help contribute to the development of novel targeted therapies. Thus far, it has been difficult to recommend HE4 as a therapeutic target owing to the fact that its role in the progression of EOC has not been extensively evaluated. This review summarizes what is collectively known about HE4 signaling and how it functions to promote tumorigenesis, chemoresistance, and metastasis in EOC, with the goal of providing valuable insights that will have the potential to aide in the development of new HE4-targeted therapies.
Citation/Publisher Attribution
James NE, Chichester C and Ribeiro JR (2018) Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer. Front. Oncol. 8:124. https://doi.org/10.3389/fonc.2018.00124
Available at: https://doi.org/10.3389/fonc.2018.00124
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.